Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
Create a narrative
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
59.6% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
2
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
30.1% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
2
users have liked this narrative
0
users have commented on this narrative
10
users have followed this narrative
New
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
20.1% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
2
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Hiscox
AN
AnalystConsensusTarget
Consensus Narrative from 15 Analysts
New Bermuda Tax And Catastrophe Risks Will Reduce Future Profitability
Key Takeaways High capital returns constrain future expansion and operational investment, potentially affecting net margins and earnings. New Bermuda tax increases and anticipated catastrophe losses may compress net margins and profitability.
View narrative
UK£14.32
FV
12.0% undervalued
intrinsic discount
13.41%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
7 days ago
author updated this narrative
RENK Group
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
European Defense Budgets And NXP R&D Will Unlock Future Opportunities
Key Takeaways Increased European defense budgets could boost RENK Group's revenue through new and expanded contracts. RENK's R&D efforts and collaborations may drive innovation, resulting in new revenue streams and long-term earnings growth.
View narrative
€69.24
FV
1.4% undervalued
intrinsic discount
18.64%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
18
users have followed this narrative
7 days ago
author updated this narrative
Elanco Animal Health
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
Zenrelia And Credelio Quattro Launches Will Expand Market Presence But FX Headwinds May Impact Earnings
Key Takeaways Strategic divestment and product launches are enhancing financial stability by reducing debt and increasing investment capacity, aiming to improve net margins. Focus on innovation, balanced portfolio, and geographic expansion is expected to drive revenue growth in pet and farm animal markets, boosting earnings.
View narrative
US$15.55
FV
9.5% undervalued
intrinsic discount
4.23%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
8
users have followed this narrative
7 days ago
author updated this narrative
Upstart Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 14 Analysts
Model 19 And HELOC Expansion Will Strengthen Underwriting And Funding
Key Takeaways Improvements in underwriting, automation, and personalization enhance loan approval rates, lower costs, and reduce default risks, positively impacting revenue and net margins. Strategic HELOC growth, backed by strong banking relationships, alongside expanded borrower base, sets stage for future revenue growth and earnings support.
View narrative
US$67.36
FV
23.0% overvalued
intrinsic discount
28.67%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
100
users have followed this narrative
7 days ago
author updated this narrative
Verona Pharma
AN
AnalystConsensusTarget
Consensus Narrative from 9 Analysts
Ohtuvayre Launch And EU Approval Will Unlock Future Markets
Key Takeaways Rapid adoption of Ohtuvayre for COPD and strong prescription growth suggest significant future revenue potential. Global regulatory advancements and strategic financing bolster potential for new revenue streams and acquisitions.
View narrative
US$106.22
FV
0.7% undervalued
intrinsic discount
119.54%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
7 days ago
author updated this narrative
MP Materials
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts
New Equipment And NdPr Trials Will Spur Production Advances
Key Takeaways Strategic investments in new processes and equipment aim to boost production, efficiency, and margins across multiple segments, enhancing revenue and profitability. Expanding rare earth products into ex-China markets with key partnerships is expected to increase revenue opportunities and improve sales volumes and pricing.
View narrative
US$50.67
FV
29.1% overvalued
intrinsic discount
58.51%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
57
users have followed this narrative
7 days ago
author updated this narrative
Dollar Tree
AN
AnalystConsensusTarget
Consensus Narrative from 23 Analysts
Core Focus And 30 Conversions Will Boost Efficiency
Key Takeaways The Family Dollar sale will streamline operations, potentially improving revenues and net margins through a focus on core business activities. Expanded multi-price assortments and store format changes could drive higher sales, improving customer basket size and positively impacting earnings.
View narrative
US$100.35
FV
15.3% overvalued
intrinsic discount
6.22%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
16
users have followed this narrative
7 days ago
author updated this narrative
UL Solutions
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts
Expansions In Texas, Italy And Japan Will Deliver Mixed Effects
Key Takeaways Planned expansions and new facilities could increase capital expenditures, impacting free cash flow but potentially supporting future revenue growth. Global macroeconomic uncertainty and geopolitical risks may affect product demand, innovation, and revenue stability despite efforts to capture market growth.
View narrative
US$70.60
FV
3.5% overvalued
intrinsic discount
6.35%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
7 days ago
author updated this narrative
Akeso
AN
AnalystConsensusTarget
Consensus Narrative from 20 Analysts
Cadonilimab And Ivonescimab Trials Will Broaden Market Access
Key Takeaways Akeso's strategic focus on bispecific antibodies and NRDL inclusion could drive significant revenue growth and expand market access. Collaborations and a robust R&D pipeline signal long-term growth and potential market expansion, bolstering future earnings and global positioning.
View narrative
HK$118.36
FV
37.7% overvalued
intrinsic discount
56.67%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
7 days ago
author updated this narrative
Value any company in seconds
Popular companies